Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.80 (-3.16%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £109.34m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Former senior Rio Tinto executive appointed

7 Jun 2017 07:00

RNS Number : 3363H
Berkeley Energia Limited
07 June 2017
 

BERKELEY ENERGIA LIMITED

 

NEWS RELEASE | 7 June 2017 | AIM/ASX: BKY

 

Former senior Rio Tinto executive appointed as a Non-Executive Director

 

Berkeley Energia is pleased to announce that highly respected London-based mining executive Mr Nigel Jones has been appointed as an independent Non-Executive Director of the Company, effective today.

Mr Jones has thirty years' experience in the international mining sector. He has considerable corporate development and marketing expertise, including being responsible for the negotiation of key uranium supply agreements for Rio Tinto.

Mr Jones spent two decades at Rio Tinto, where ultimately he held the position of Global Head of Business Development and prior to that Managing Director of Rio Tinto Marine, Head of Investor Relations and Marketing Director, Uranium.

Mr Jones was recently appointed as Head of Private Side Capital Markets at ICBC Standard Bank, the global markets subsidiary of ICBC Bank, which is the world's largest bank by assets.

Mr Jones is an Oxford University graduate and has completed a Corporate Finance Programme at the London Business School.

 

Mr Jones will replace Dr Jim Ross, who is today retiring from the Board after over twelve years of service.

 

Paul Atherley, Managing Director, commented:

 

"We are delighted to welcome Nigel to the Board, a key appointment in step with the Company's transition into a European-focused uranium developer and producer.

 

We believe his considerable experience in corporate development and marketing of uranium products will be of considerable value to the Company.

 

On behalf of the Board and the rest of the Company, I would like to sincerely thank Dr Ross for his guidance and many contributions to the highly successful transformation of the Company from a junior explorer to an institutionally backed European uranium developer. We wish him all the best in his future endeavours."

For further information please contact:

Berkeley Energia Limited

+44 20 3903 1930

Paul Atherley, Managing Director

info@berkeleyenergia.com

Hugo Schumann, Chief Commercial Officer

Peel Hunt LLP (Joint Broker)

+44 20 7418 8900

Matthew Armitt

Ross Allister

Chris Burrows

WH Ireland Limited (Nominated Adviser)

+44 20 7220 1666

Paul Shackleton

Nick Prowting

Jay Ashfield

Buchanan

+44 207 466 5000

Bobby Morse, Senior Partner

BKY@buchanan.uk.com

Anna Michniewicz, Account Director

 

Mr Nigel Hanson Jones's (aged 51) directorships in the last five years are as follows:

Company

Status

Redbeck Partners Ltd

Current

Avalite Resources Ltd

Current

Rio Tinto Medical Plan Trustees Ltd

Previous

Rio Tinto Uranium Ltd

Previous

Rio Tinto Iron Ore Asia Pte Ltd

Previous

Rio Tinto Shipping (Asia) Pte Ltd

Previous

Rio Tinto Procurement (Singapore) Pte Ltd

Previous

 

There are no other disclosures required in accordance with Rule 17 or Schedule 2(g) of the AIM Rules.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAKKKEEAXEFF
Date   Source Headline
29th Apr 20267:00 amRNSQuarterly Report March 2026
28th Apr 20267:00 amRNSCeasing to be a Substantial Holder
11th Mar 20267:00 amRNSHalf Year Accounts
11th Mar 20267:00 amRNSHalf Year Accounts
6th Feb 20267:00 amRNSFiling of US$1.25 Billion Statement of Claim
29th Jan 20267:00 amRNSQuarterly Report December 2025
21st Jan 20267:00 amRNSChange in Substantial Holder Notice
24th Dec 20257:00 amRNSIssue of Shares on Exercise of Unlisted Options
19th Dec 20257:00 amRNSReport on Payments to Governments
19th Dec 20257:00 amRNSReport on Payments to Governments
28th Nov 20257:00 amRNSResults of Annual General Meeting
31st Oct 20257:00 amRNSQuarterly Report September 2025
28th Oct 20257:00 amRNSPositive Met Test Work Results at Conchas
23rd Oct 20257:00 amRNSNotice of AGM
3rd Oct 20257:00 amRNSDate of Annual General Meeting
29th Aug 20257:00 amRNSChange in Substantial Holder Notice
27th Aug 20257:03 amRNS2025 Annual Report
31st Jul 20257:00 amRNSQuarterly Report June 2025
30th Apr 20257:00 amRNSQuarterly Report March 2025
23rd Apr 20257:00 amRNSChange in Substantial Holder
25th Mar 20257:00 amRNSASX Price Query
13th Mar 20257:00 amRNSHalf-year Report
31st Jan 20257:00 amRNSQuarterly Report December 2024
29th Jan 20257:00 amRNSShallow, thick zones lithium, rubidium intersected
27th Dec 20247:00 amRNSReport on Payments to Govts
19th Nov 20247:00 amRNSResult of AGM
30th Oct 20247:00 amRNSQuarterly Report September 2024
17th Oct 20247:00 amRNSNotice of Substantial Holder
9th Oct 20247:00 amRNSNotice of AGM
24th Sep 20247:00 amRNSDate of Annual General Meeting
27th Aug 20247:00 amRNS2024 Annual Report
31st Jul 20247:00 amRNSQuarterly Report June 2024
28th May 20247:59 amRNSRequest for Arbitration Submitted against Spain
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.